Changmao Biological (00954.HK) issued a profit warning, expecting that the interim net loss attributable to shareholders will narrow to between 4 million and 6 million yuan compared to the same period last year.

According to the Zhichun Finance APP, Changmao Biochemical (00954.HK) announced that the group expects to report a consolidated net loss attributable to the Companys shareholders of approximately RMB 4 million to RMB 6 million for the six months ending June 30, 2026, a significant narrowing compared to the consolidated net loss attributable to the Companys shareholders of RMB 25.79 million for the six months ending June 30, 2025.